Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vericel CorpVCEL · Entity 4481 | Chief Legal Officer | June 26, 2026 | June 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vericel Corp
Report date June 26, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,647 |
Last balance in matching sequence
After 2026-06-26 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 16,647 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 2 · 2026-06-26 · Sale · Disposed 15,000 · Balance 1,647 F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.25 · Expires 2029-11-04 | Direct | 55,000 |
Reported balance
After 2026-06-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 55,000 F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2024 Filed Jun 24, 2024 22:21 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 6,772 | $45.02 | $304,875.44 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 4 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 487 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 22:21 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 6,772 | $16.25 | $110,045.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,754 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · derivative · entry 7 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,246 Underlying: Common Stock · 6,754 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 6,754 | $45.04 | $304,200.16 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 487 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 22:21 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 6,754 | $16.25 | $109,752.50 |
DisclosureSEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:07 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 8,115 | $45.33 | $367,852.95 |
DisclosureSEC source: 0001140361-24-012608 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 08, 2024 Filed Mar 15, 2024 20:05 UTC Amendment | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 8,115 | $45.33 | $367,852.95 |
DisclosureSEC source: 0001140361-24-013494 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2023. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009492 · form4.xml · derivative · entry 2 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 22, 2025. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $48.31 | $0.00 |
DisclosureSEC source: 0001140361-24-009492 · form4.xml · derivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: These options shall begin vesting on February 22, 2024 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · derivative · entry 9 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share. F5 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025. F7 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,325 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · derivative · entry 8 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,650 Underlying: Common Stock · 2,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share. F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively. F7 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · derivative · entry 7 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F7 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 777 | $49.50 | $38,461.50 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 6 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,282 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 5 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 1,032 | $49.50 | $51,084.00 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 4 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,309 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 1,441 | $49.50 | $71,329.50 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,016 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:07 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 106 | $37.45 | $3,969.70 |
DisclosureSEC source: 0001140361-23-057880 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,467 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:07 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 1,432 | $34.20 | $48,974.40 |
DisclosureSEC source: 0001140361-23-057880 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,573 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | Vericel Corp VCEL · Entity 4481 | GiftCommon Stock | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-053859 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,005 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 19, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · derivative · entry 9 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F9 · price: The Fair Market Value of the vested derivative securities is $29.82 per share. F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025. F8 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 19, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 832 | $29.82 | $24,810.24 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 4 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,176 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 19, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,325 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · derivative · entry 8 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 2,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F9 · price: The Fair Market Value of the vested derivative securities is $29.82 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. F8 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 1,155 | $29.82 | $34,442.10 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,258 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · derivative · entry 7 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F8 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 28,125 | $0.00 Strike: $29.82 | $0.00 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · derivative · entry 6 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,125 Underlying: Common Stock · 28,125 shares Expires 2033-02-17 F5 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 01:51 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 1,875 | $0.00 Strike: $29.82 | $0.00 |
DisclosureSEC source: 0001127602-23-006580 · form4.xml · derivative · entry 5 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires 2033-02-17 F5 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| September 30, 2022 Filed Feb 13, 2023 21:39 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 25 | $19.72 | $493.00 |
DisclosureSEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,088 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2022 Filed Feb 13, 2023 21:39 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 403 | $21.40 | $8,624.20 |
DisclosureSEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,063 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 31, 2022 Filed Feb 13, 2023 21:39 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 215 | $32.49 | $6,985.35 |
DisclosureSEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 19, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $34.90 | $61,075.00 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 19, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 869 | $34.90 | $30,328.10 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,445 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 19, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 2,865 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 6 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,865 Underlying: Common Stock · 2,865 shares Expires 2032-02-18 F6 · derivative.exercise_date: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 5 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,300 shares Expires not disclosed F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:08 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 51,385 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 4 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,385 Underlying: Common Stock · 51,385 shares Expires 2032-02-18 F6 · derivative.exercise_date: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| September 30, 2021 Filed Feb 15, 2022 00:33 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 145 | $41.48 | $6,014.60 |
DisclosureSEC source: 0001593968-22-000467 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,564 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 7,200 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 7,200 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 7,200 | $55.11 | $396,760.32 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 7,200 | $16.25 | $117,000.00 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 2,800 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,200 Underlying: Common Stock · 2,800 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 2,800 | $55.01 | $154,028.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,800 | $16.25 | $45,500.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 10,000 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 10,000 | $51.18 | $511,786.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 10,000 | $16.25 | $162,500.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:10 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 56,110 | $0.00 Strike: $51.40 | $0.00 |
DisclosureSEC source: 0001593968-21-000544 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,110 Underlying: Common Stock · 56,110 shares Expires 2031-02-19 F1 · derivative.exercise_date: These options shall begin vesting on February 19, 2021 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.